Trial intelligence / Profile preview

Perioperative continuation versus withdrawal of ACE inhibitor/ARB therapy in non-cardiac surgery

NL-OMON25483Recruiting

Sponsor
University Medical Center Utrecht
Start
Sep 2020
Countries
1
01

Overview

Randomised, open-label trial in hypertension (HTN) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Postoperative acute kidney injury. Started Sep 2020; status: recruiting.

02

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NL-OMON25483.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON25483.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call